Homeostatic model assessment

Revision as of 13:31, 18 April 2009 by Adeeljamil (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for Homeostatic model assessment

Articles

Most recent articles on Homeostatic model assessment

Most cited articles on Homeostatic model assessment

Review articles on Homeostatic model assessment

Articles on Homeostatic model assessment in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Homeostatic model assessment

Images of Homeostatic model assessment

Photos of Homeostatic model assessment

Podcasts & MP3s on Homeostatic model assessment

Videos on Homeostatic model assessment

Evidence Based Medicine

Cochrane Collaboration on Homeostatic model assessment

Bandolier on Homeostatic model assessment

TRIP on Homeostatic model assessment

Clinical Trials

Ongoing Trials on Homeostatic model assessment at Clinical Trials.gov

Trial results on Homeostatic model assessment

Clinical Trials on Homeostatic model assessment at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Homeostatic model assessment

NICE Guidance on Homeostatic model assessment

NHS PRODIGY Guidance

FDA on Homeostatic model assessment

CDC on Homeostatic model assessment

Books

Books on Homeostatic model assessment

News

Homeostatic model assessment in the news

Be alerted to news on Homeostatic model assessment

News trends on Homeostatic model assessment

Commentary

Blogs on Homeostatic model assessment

Definitions

Definitions of Homeostatic model assessment

Patient Resources / Community

Patient resources on Homeostatic model assessment

Discussion groups on Homeostatic model assessment

Patient Handouts on Homeostatic model assessment

Directions to Hospitals Treating Homeostatic model assessment

Risk calculators and risk factors for Homeostatic model assessment

Healthcare Provider Resources

Symptoms of Homeostatic model assessment

Causes & Risk Factors for Homeostatic model assessment

Diagnostic studies for Homeostatic model assessment

Treatment of Homeostatic model assessment

Continuing Medical Education (CME)

CME Programs on Homeostatic model assessment

International

Homeostatic model assessment en Espanol

Homeostatic model assessment en Francais

Business

Homeostatic model assessment in the Marketplace

Patents on Homeostatic model assessment

Experimental / Informatics

List of terms related to Homeostatic model assessment

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch. } The homeostatic model assessment (HOMA) is a method used to quantify insulin resistance and Beta-cell function. It was first described under the name HOMA by Matthews et al in 1985.

Derivation

The HOMA authors used data from physiological studies to develop mathematical equations describing glucose regulation as a feedback loop [1]. They published computer software that solves the equations, so that insulin resistance and beta-cell function can be estimated from fasting glucose and insulin levels. They also published an equation (see below) that gave approximately the same answers as an early version of the computer software [2]. However, the computer model has since been improved to better reflect human physiology and recalibrated to modern insulin assays, and the developers have written that they recommend the computer software be used wherever possible [3] [4].

Notes

The HOMA model was originally designed as a special case of a more general model called HOMA-CIGMA [5].

The approximating equation for insulin resistance, in the early model, used a fasting blood sample, and was derived by use of the insulin-glucose product, divided by a constant:

Glucose (mg/dL)) x Insulin (µU/mL) / 405

In this equation, one should use the constant 22.5 instead of 405 if the glucose is reported in mmol/L. This model correlated well with estimates using the euglycemic clamp method (r = 0.88).

The authors have tested HOMA extensively against other measures of insulin resistance (or its reciprocal, insulin sensitivity) and beta-cell function [6] [7] [8].


References

  1. Turner et al. (1979) Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism 28: 1086-96.
  2. Matthews et al. (1985) Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-9.
  3. Wallace et al. (2004) Use and Abuse of HOMA modeling. Diabetes Care 27:1487-95.
  4. Levy et al. (1998) Correct Homeostasis Model Assessment (HOMA) Evaluation uses the computer program. Diabetes Care 21: 2191-2.
  5. Turner et al. (1993) Measurement of insulin resistance and beta-cell function: the HOMA and CIGMA approach. Current topics in diabetes research (eds) F. Belfiore, R. Bergman and G. Molinatti Front Diabetes. Basel, Karger 12: 66-75
  6. Hermans et al. (1999) Comparison of tests of ß-cell function across a range of glucose tolerance from normal to diabetes. Diabetes 48: 1770–86
  7. Hermans et al. (1999b) Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes Diabetologia 42: 678–87
  8. Wallace et al. (2004) Use and Abuse of HOMA modeling. Diabetes Care 27:1487-95.

External links

http://www.dtu.ox.ac.uk/homa/ Template:SIB Template:WikiDoc Sources